The decision-making mechanisms that determine the choice of the appropriate effector immune response to a microbial challenge are poorly understood. The endocannabinoid 2-arachidonoylglycerol (2-AG), injected intradermally in mice together with a soluble protein and a T helper-2 (Th2) priming Toll-like receptors (TLRs) agonist during primary immunization, shifts the memory response to the Th1 type. This effect can be shown by the enhanced hypersensitivity response and by the Th1 pattern of cytokines production that was abolished by the specific cannabinoid receptor CB2 antagonist SR 144528. 2-AG seems to operate during the innate response by increasing the number of dendritic cells (DCs) migrating to the draining lymph nodes. Expression of CB2 mRNA but not of the protein was higher in immature vs. mature DCs. Consistently, in vitro, 2-AG exerted a potent chemotactic activity on both immature and mature DCs. In conclusion, we suggest that, in vivo, the endocannabinoid 2-AG may act as chemotactic substance capable of recruiting DCs and/or their precursors during the innate immune response that, in presence of a TLR agonist, consequently instruct a Th1-shifted adaptive response. As 2-AG may be induced in tissues by various stimuli at concentrations similar to that used in our study, this evidence might be of a wide-ranging pathophysiological relevance.
n general, the dose and form of antigen, the route of its administration and the delivery of the appropriate costimulatory signals by DCs may determine whether an antigen primes for an appropriate memory effector response (1) (2) (3) . In particular, the presentation of processed antigens in association with class I and II major histocompatibility complex (MHC) molecules by DCs in absence of maturation stimuli leads to tolerance. In contrast, if maturation stimuli such as those delivered by microbial products are coadministered with antigens, immunity develops (4) . Microbial products stimulate toll-like receptors (TLRs) in DCs activating the innate immune response to produce inflammatory mediators and modulating expression of costimulatory molecules and type and kinetic of cytokine produced (5, 6) . Nevertheless, the local microenvironment, which may differ according to the route of entry of the infectious agent, may affect these mechanisms (7, 8) .
On this line, we reported that catecholamines may affect DCs migration (9, 10) and showed that cytokine production and the extent of Th1 differentiation in the response to an antigen might be influenced by activation of α2-and β2-adrenergic receptors in the early phase of dendritic cell stimulation (10) . More recently, we found that the extent of Th1 priming in the adaptive response to a skin sensitizer seems to depend also on its ability to modulate the local sympathetic nervous activity during the innate immune response (11) .
Endogenous cannabinoid such as anandamide and 2-AG may be produced in most tissues upon a variety of stimuli, including TLRs agonist and traumatic injury (12, 13) . These substances act as physiological ligands for the G protein-coupled cannabinoid receptors CB1 and CB2, with CB2 receptors being expressed mostly in immunocompetent cells (13) . Interestingly, human myeloid DCs express both the cannabinoid CB1 and CB2 receptors and produce 2-AG (14) .
Relevant to our previous work, the peripheral sympathetic nervous system activity may be inhibited by activation of presynaptic cannabinoid CB1 receptors (15, 16) . Therefore, we asked the question whether the presence of 2-AG during the innate immune response to a soluble protein could influence the ensuing adaptive response. Here, we show that a single injection of 2-AG during primary immunization with a soluble protein and a TLR2 agonist may influence the recall memory response inducing a Th1-shift, possibly by increasing the number and/or type of DCs migrating from the site of antigen deposition to the draining lymph nodes. MA
MATERIALS AND METHODS

Mice
C57BL/6 inbred mice were purchased from Harlan, Italy. All the mice used in the experiments were female, 2−4-months old and were maintained in our animal room under a standard 12 h photoperiod, at 21 ± 1°C, with food and water ad libitum.
Reagents and antibodies
Peptidoglycan (PGN) from S. aureus and 2-arachidonoylglycerol were purchased from Sigma (St. Louis, MO, USA). Phycoerythrin (PE)-conjugated anti CD11c+ mAbs were purchased from PharMingen, Becton Dickinson (Franklin Lakes, N.J.), Allschwill (Basel, Switzerland). FITCconjugated ovalbumin (OVA-FITC) was purchased from Molecular Probes (Luzern, Switzerland). The specific cannabinoid CB2 receptor antagonist SR 144528 was a kind gift from Sanofi-Synthelabo (Paris, France).
Purification of splenic CD8+, CD11c+ and CD8-,CD11c+ DCs from bone marrow cultures CD8+, CD11c+ DCs were purified from spleens of C57BL/6 mice. Single-cell suspension was obtained by gentle teasing. CD11c+ DCs were separated by negative magnetic selection using CD8+ Dendritic Cell Biotin-antibody cocktail and anti-biotin microbeads followed by positive selection of CD8+ cells using microbeads-conjugated antibodies (Miltenyi Biotech, Belgisch Gladbach, Germany) and a magnetic cell separator according to the manufacturer's instructions, resulting in >90% purity of CD8+,CD11c+ DCs. Bone marrow-derived CD8-, CD11c+ DCs were generated in culture and purified by magnetic cell sorting as described previously (10) . The concentration of CD11c+ cells obtained was always >95% as assessed by flow cytometry (FACScan, Becton Dickinson, Allschwill, Switzerland).
In certain experiments the three DCs subsets were stimulated overnight by PGN (10 µg/ml) in RPMI 1640, 25 mM HEPES, 10% FCS, 50 µM 2-mercaptoethanol, 2 mM L-glutamine, 100 IU/ml penicillin, 100 µg/ml streptomycin, and 10 ng/ml granulocyte/macrophage-colony stimulating factor (complete culture medium CCM).
In vivo immunization and recall response
Groups of mice were injected intradermally (id) in the back with key-hole limpet haemocyanin (KLH, 50 µg), 2-AG (50 µM) and PGN (10 µg/ml) dissolved in 100 µl of PBS. Ten days later, the mice were injected subcutaneously (sc) with 50 µg of KLH dissolved in 50 µl of PBC/Freund's complete adjuvant (CFA) and again after 7 days challenged sc with 50 µg in 20 µl PBS in the right hind footpad. 48 h later the DTH response and cytokine production in cell suspension from the popliteal lymph nodes were assessed.
Cytokines in lymph node cells and delayed hypersensitivity (DTH) response
Groups of mice were immunized as reported above. The DTH response was assessed by measuring the degree of foot swelling of the KLH-injected foot compared with that of the vehicle-treated contralateral foot at 48 h after challenge using a digital micrometer (Mitutoyo, Japan).
After having assessed the DTH response, draining lymph node cells were obtained, seeded in microplates at 5 × 10 5 cells / 200 µl / well, and incubated in RPMI 1640, 10% FCS at 37°C for 72 h in the presence of 10 µg/ml of KLH. Next, culture supernatants were collected and the concentration of IFN-γ and IL-4 measured by ELISA (Becton Dickinson).
In vivo migration
Mice were injected id with OVA-FITC (50 µg) plus PGN ± 2-AG in the hind foot pads, and 24 h later the mice were killed and single-cell suspensions were prepared from the popliteal draining lymph nodes. Lymph nodes were incubated in collagenase A, 0.5 mg/ml and DNase I (Boehringer Mannheim, Rot Kreuz, Switzerland) for 10 min at 37°C. Afterward, the tissue was gently teased, and cells were filtered through a 70-µm cell strainer (Falcon). Cells were washed and CD11c+ cells were positively selected by magnetic cell sorting after labeling the cells with anti-CD11c Microbeads (Miltenyi Biotech). Cells were then washed and labeled with PEconjugated anti-CD11c monoclonal antibody and analyzed by flow cytometry.
Real-time reverse transcriptase polymerase chain reaction (RT-PCR)
Total RNA isolated from DCs subsets was reverse transcribed using random examers and the TaqMan Reverse Transcription kit (Perkin-Elmer Applied Biosystems, Foster City, CA). A relative quantification of CB2 mRNA was done in a Rotor Gene 2000 (Corbett Research, Mortlake, Australia) using predeveloped reagents (PROLIGO, Paris, France). This assay uses the hydrolysis of an internal fluorogenic probe to monitor the amplification of the target. When the probe is intact, the two fluorophores interact such that the emission of the reporter dye is quenched. During amplification, the probe is hydrolyzed, relieving the quenching of the reporter and resulting in an increase in its fluorescence intensity. This change in the reporter dye fluorescence is quantitative for the amount of PCR product. Amplification of 18S rRNA was done for each sample as endogenous control of the amount and quality of total RNA added to each reaction. Thermal cycling conditions were 2 min at 50°C and 15 min at 95°C, followed by 40 cycles of 3-steps PCR consisting of 15 s at 94°C, 30 s at 55°C and 30 s at 72°C. All samples were amplified in duplicate. Threshold cycle, Ct which correlates inversely with the target mRNA levels, was measured as the cycle number at which the reported fluorescence emission increased above a threshold level. For each sample, the amount of target mRNA (CB2) was expressed as an n-fold difference relative to the amount of target mRNA in control tissue (brain). The formula used to determine this value is 2 -∆∆Ct , where ∆Ct is determined by subtracting the average 18S rRNA value from the average target Ct value. The calculation of ∆∆Ct involves the subtraction of the ∆Ct of control from the target ∆Ct value.
Western blot analysis
Western immunoblotting was performed according to a method described previously (14) with some modification. Briefly, DCs were homogenized in lysis buffer (125 mM Tris-Hcl, pH 6.8; 25% glycerol, 2% SDS), incubated at 4°C for 30 min and centrifuged at 14,000 g for 10 min. Samples were subjected to SDS-PAGE and transferred from the gels onto polyvinylidene fluoride membranes. The membranes were preincubated with 5% nonfat dry milk in NaCl/Tris for 30 min to block nonspecific binding. To determine CB2 receptor expression, the blots were then incubated with polyclonal antibodies raised in rabbits against the residues 20−33 of the human/mouse CB2 receptor (1: 1000, Cayman Chemicals, Ann Arbor, MI, USA). Antigen preabsorption experiments were performed with 10 µg of the CB2 antibody in 100 ml PBS in presence or absence of 300 µg of the corresponding immune peptide (Cayman Chemicals). Western blots were subsequently done with the abovementioned antibody dilution. Then, the membrane was washed 3 × 10 min in NaCl/Tris containing 0.05% Tween-20 (NaCl/Tris/Tween) and incubated with goat anti-rabbit IgG antibody conjugated with alkaline phosphatase (DAKO AG, Zug, Switzerland). The membrane was washed again in NaCl/Tris/Tween and rinsed in the staining buffer (Tris/NaCL 0.1 M, MgCl 2 50 mM, pH 9). Signals were detected by addition of the staining solution containing 100 ml staining buffer, 200 µl of nitro blue tetrazolium (75 mg/ml in 70% dimethylformamide, Sigma) and 200 ml of 5-bromo-4-cloro indolylphosphate (50 mg/ml in dimethylformamide, Sigma).
In vitro migration
The chemotactic activity of 2-AG was evaluated in vitro using a chemotaxis chamber technique. Twenty-seven microliters of a chemoattractant solution containing 2-AG at different concentrations or control medium RPMI 1640, 1% FCS were added to the lower wells of a chemotactic chamber (Neuroprobe, Gaithersburg, MD, USA). A polycarbonate filter (5 µm pore size, Neuroprobe) was layered onto the wells and covered with a silicon gasket and a top plate. Fifty microliters of DC suspensions (1.5 × 10 6 cells/ml) were seeded in the upper chamber. For checkerboard analysis, 2-AG was added also in the upper wells together with DCs. DCs were either immature as obtained from bone marrow cultures or brought to maturation by incubation with PGN for 24 h. The chamber was incubated at 37°C for 90 min. At the end of the incubation, filters were removed, stained with Diff-Quick (Dade Behring, Düdingen, Switzerland), and high power fields (×100) were counted. Results are expressed as a chemotactic index obtained by dividing the mean number of cells migrated in 10 fields in response to 2-AG by the mean number of cells migrated in response to medium alone.
Statistical analysis
Statistical significance of the differences was assessed by ANOVA, performed with the computer-assisted software JMP.
RESULTS
In vivo effect on Th priming
We studied the influence of 2-AG in a model in which a soluble foreign protein was injected in combination with peptidoglycan (PGN) from S. aureus to provide a danger signal to DCs. TLR2 recognizes the highest number of microbial products and PGN is a TLR2 agonist that has been reported to instruct myeloid DCs to induce a Th2 response (17, 18) . Mice were injected with KLH and PGN in presence or absence of 2-AG (50 µM). The concentration of 2-AG used was similar to those induced in tissues by inflammatory stimuli or traumatic injury (12, 13) . Ten days later, the mice were boosted subcutaneously with KLH (50 µg) in CFA. After a further seven days the mice were challenged with KLH (50 µg in 20 µl PBS) in the right hind footpad to evaluate the DTH response and cytokine production in draining popliteal lymph nodes. Figure 1 shows the results obtained. Addition of PGN to KLH during primary immunization resulted in a mixed Th1/Th2 response as assessed by the DTH response, IFN-γ, and IL-4 production in draining lymph node cells. The presence of 2-AG resulted in a significantly higher DTH response upon the recall memory response (Fig. 1A) and in a strong inhibition of IL-4 production (Fig. 1B) . The production of IFN-γ remained unchanged (Fig. 1B) . These effects were neutralized when the specific CB2 antagonist SR 144528 was injected together with 2-AG in the primary immunization. Thus, 2-AG exerted a Th1-skewing effect during primary immunization via CB2 receptors.
Expression of the CB2 receptor in murine DCs subsets
Expression of CB2 receptors has been reported in human myeloid DCs (14) , but no data are available for murine DCs. We investigated the CB2 receptor mRNA expression by real-time RT-PCR in lymphoid CD8+, CD11c+ and CD8-, CD11c+ DC populations that were purified from the spleen of C57BL/6 mice or obtained from bone marrow cell cultures, respectively. We performed a semiquantitative analysis of the CB2 mRNA expression in immature and mature DC subsets using brain RNA as reference. Figure 2 shows that CD8+CD11c+ DCs showed the highest expression of the CB2 mRNA and that both subsets of immature DCs showed higher expression of the CB2 mRNA if compared with the control brain tissue. The CB2 expression was, however, reduced to the brain level upon maturation by PGN.
Effect on DCs migration in vivo and in vitro
The number, type, and kinetics of DCs migrating from the site of antigen deposition to the draining lymph nodes control their Th priming ability (5, 6). 2-AG has been reported to enhance the migration of cells expressing the CB2 receptor (19, 20) . Therefore, we thought that the effect of 2-AG could be related to an enhanced migration of DCs and antigen presentation. To challenge this hypothesis we injected OVA-FITC (50 µg) as foreign protein ± 2-AG, and 24 h later, we enumerated the CD11c+FITC+ and the CD8+FITC+ cells in the CD11c+-enriched cell population from the draining lymph nodes. Table 1 shows that 2-AG indeed increased the number of DCs loaded with OVA-FITC in the draining lymph nodes with the CD8+FITC+ subpopulation being more affected. When the CD11c+FITC+ general population was considered, the percent increase in migration was of 163% (P < 0.03) while by considering the CD8+FITC+ subset only, the figure rose to 364% (P < 0.01). The presence of SR 144528 counteracted completely these effects ( Table 1 ), indicating that the increase in the antigen-loaded DCs was a CB2-mediated phenomenon.
Immature bone marrow-derived DCs and/or DCs matured by exposure to PGN were assayed for their capacity to migrate in vitro toward various concentrations of 2-AG. Figure 3 shows that 2-AG may exert a powerful chemotactic activity on both immature and mature DCs. Checkerboard analysis showed that this effect was real chemotaxis, as 2-AG was ineffective in absence of a concentration gradient, that is, when it was present in both upper and lower wells of the chemotactic chamber (Fig. 3) . The CB2 antagonist SR 144528 inhibited completely the chemotactic effect of 2-AG (Fig. 3) , indicating that the effect observed was CB2 mediated.
Western blot analysis
The effects of 2-AG in vivo and in vitro were completely counteracted by SR 144528 suggesting that all the effects observed were CB2-mediated. However, the chemotactic activity of 2-AG did not correlate with the different CB2 mRNA expression in immature vs. mature DCs. To investigate this point, we studied whether the different mRNA expression was reflected by a different receptor protein expression. We performed a Western immunoblotting and found that both immature and mature DCs apparently express a similar amount of the CB2 protein (Fig. 4) . Thus, overnight incubation with PGN caused a reduced CB2 mRNA expression that was not reflected in a reduced CB2 protein expression.
DISCUSSION
Here, we have shown that the endogenous cannabinoid 2-AG may shift the adaptive immune response to a foreign soluble protein toward the Th1 type, probably via CB2 receptors in DCs and/or DC precursors. To exert its action, 2-AG had to be injected together with a TLR2 agonist to provide a "danger signal" to DCs. The effect of 2-AG was evident in the recall memory response in spite of it being injected only once during primary immunization. As exogenous or endogenous 2-AG is rapidly metabolized by a variety of cell types (13) , it seems reasonable to assume that its effect was exerted during the innate phase of the immune response; hence, the 2-AG influenced the Th priming ability of DCs. As a matter of fact, 2-AG increased the number of DCs migrating from the site on antigen injection to the draining lymph nodes and exerted a potent chemotactic activity on DCs in vitro.
The lower expression of the CB2 mRNA shown by mature DCs did not correlate either with the chemotactic activity of 2-AG or the CB2 protein expression that was similar in both immature and mature DCs. This finding confirms a previous study in which a similar behavior of the CB2 receptor is described upon LPS stimulation of human DCs (14) . However, the ability of 2-AG to attract mature DCs is rather puzzling because, if exerted at the site of antigen deposition, it would possibly decrease DCs migration to the draining lymph nodes. Perhaps, this phenomenon might reflect a function of 2-AG in lymphoid tissues where maturing peripheral DCs have to migrate for antigen presentation. On the other hand, as 2-AG is rapidly metabolized (13), its action is probably short and would not involve mature DCs at least in peripheral organs like the skin.
The observation that 2-AG may especially increase the number of antigen-loaded CD8+ DCs in the draining lymph nodes suggests that its action is possibly exerted on circulating DCs precursors. In fact, the skin does not contain CD8+ DCs, and 2-AG has been reported to act as a chemoattractant for human monocytes and macrophages (20) and in general for hematopoietic cells expressing the CB2 receptor (19) . Interestingly, monocytes were suggested to represent immediate precursors for both CD8− and CD8+ DCs (21) . It seems worth mentioning that both these DC subsets do, in fact, express the CB2 mRNA. Once recruited, DCs engulf and process the foreign protein, while maturing upon the TLR2 stimulation. Finally, they migrate to the draining lymph nodes where they present the antigen to Th cells. The quality and quantity of the DC subset may influence Th priming (5, 22) . During in vivo T cell responses, CD8-DCs mainly induce Th2 responses, whereas CD8+ DCs elicit Th1 responses because of their high capacity to produce IL-12 (22) . Also, the kinetics of DC migration may influence Th priming. Recently activated DCs were described to prime in vitro Th1 responses, whereas at later time points, the same cells preferentially prime Th2 cells (5) . Consistently, the apparent Th1 adjuvant effect of 2-AG seems to result from a reduced Th2 priming (decrease of IL-4 production) rather than from an increased Th1 polarization (no increase of IFN-γ production). On the other hand, in vitro and in vivo studies indicate that the functional division between CD8+ and CD8-DCs can be altered by environmental factors that modulate the function of DCs, in particular, the ability to produce IL-12 (10, 11, 22) . Thus, both the increased migration and type of DCs subset might explain the final effect on Th priming. We also found that 2-AG may slightly increase the expression of the costimulatory molecule CD80 in maturing DCs, but this effect did not account for the in vivo effect, because 2-AG exposure before adoptive transfer of antigen-loaded and PGN-stimulated DCs did not increase the DTH response (data not shown). Thus, we suggest that 2-AG might preferentially recruit CD8+ DCs precursors and/or create a microenvironment in vivo that instructs DCs to skew the Th response to a foreign soluble protein toward the Th1 type.
2-AG may be produced upon a variety of stimuli including the TLR4 agonist LPS (13, 14) that on the other hand may induce a Th1 response (17) . It would be interesting to study whether the in vivo Th1 cells polarizing ability of certain TLRs agonists might be related to a modulation of 2-AG production.
In conclusion, we suggest that the endocannabinoid 2-AG may act as chemotactic substance capable of recruiting DCs and/or their precursor cells during the innate immune response, which, in the presence of a TLR2 agonist, consequently instruct a Th1 adaptive response. In the past several years, cannabimimetic agents have been reported to exert both anti-inflammatory and pro-inflammatory effects resulting in a complex and controversial picture (23, 24) The Th2-Th1 shift exerted by 2-AG via activation of CB2 receptors in DCs is in contrast with recent reports showing that CB2 receptor stimulation during infection results in the opposite effect, that is, in a Th1-Th2 shift (25, 26) . However, one study (25) was performed in vitro by exposing human DCs to ∆ 9 -tetrahydrocannabinol and therefore cannot be compared with our in vivo finding. In the second study (26) , mice were injected with a pharmacological dose of ∆ 9 -tetrahydrocannabinol followed 18 h later by a challenge infection with Legionella pneumophila. Therefore, the immune system was preconditioned by a pharmacological dose of ∆ 9 -tetrahydrocannabinol before any antigen challenge and, possibly, the cannabimimetic agent affected all the CB2-expressing immunocompetent cells, including T and B lymphocytes. In our case, because of its rapid metabolic degradation, 2-AG probably confined its action at the very beginning of the innate immune response by recruiting DCs and/or their precursors at the site of antigen deposition without affecting lymph node cells. In addition, the dose used was similar to the physiological levels observed in various tissues (13) . Worthy of note, a most recent report shows that 2-AG may stimulate the production of inflammatory chemokines, including IL-8 and macrophage-chemotactic protein-1 in the promyelocytic leukemia cell line HL-60 (27) . This effect is perfectly in line with our results. Thus, we believe to have revealed a potentially important role of 2-AG, which might have several implications. For example, 2-AG is induced in the central nervous system by traumatic brain injury at tissue concentrations largely above that used in our study. Its pathophysiological relevance seems to be that of attenuating brain damage via a CB1-mediated mechanism (12) . This study used a model of closed head injury, and therefore, no exogenous danger signals were involved. Perhaps, in presence of a danger signal (infection) or inflammation, the effect of 2-AG in the brain would be damaging and promote neuroinflammation.
Last but not least, the ability of 2-AG to shape the innate immune response so that the ensuing adaptive response is Th1-skewed might find it application in vaccines development. The mice were injected id in the hind foot pads with the reported antigens and treated as shown. Twenty four hours later, the mice were sacrificed, and the CD11c+FITC+ and 
